U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.

Cover of StatPearls

StatPearls [Internet].

Show details

Threatened Miscarriage

; ; .

Author Information and Affiliations

Last Update: February 12, 2024.

Continuing Education Activity

A threatened miscarriage also called a "threatened abortion" or "threatened early pregnancy loss," typically refers to vaginal bleeding and uterine cramping in an otherwise viable pregnancy before 20 weeks of gestation, though more commonly occurring in the first trimester. In a threatened miscarriage, the cervical os remains closed, and the fetus or embryo remains viable. Evaluation of threatened miscarriage depends on the pregnancy's gestational age. At early gestational ages, it is essential to establish the location of the pregnancy to rule out an ectopic pregnancy, which can also present with vaginal bleeding and lower abdominal pain. Once an intrauterine pregnancy has been established, the clinician must determine the viability of the pregnancy, which is accomplished through a pelvic examination and ultrasound. If fetal cardiac activity is not seen, serial ultrasound examinations may be required to differentiate an early viable pregnancy from a pregnancy loss. Typically, threatened miscarriages are managed expectantly with close clinical monitoring. This activity for healthcare professionals is designed to enhance the learner's competence when evaluating, implementing, and educating patients on threatened miscarriage and its management. By participating in this continuing education activity, clinicians will gain a comprehensive understanding of the risks, benefits, and monitoring parameters involved in managing threatened miscarriage, enabling them to provide evidence-based and patient-centered care.


  • Define threatened miscarriage and review how to identify it.
  • Explain the diagnostic evaluation for patients presenting with bleeding in early pregnancy.
  • Explain the management of a patient presenting with a threatened miscarriage.
  • Describe how an interprofessional team can optimize outcomes for patients with a threatened miscarriage.
Access free multiple choice questions on this topic.


A pregnancy loss or "miscarriage" generally is defined as pregnancy failure before 20 weeks of gestation.[1] A threatened miscarriage also called a "threatened abortion" or "threatened early pregnancy loss," typically refers to vaginal bleeding and uterine cramping in an otherwise viable pregnancy before 20 weeks of gestation, though more commonly occurring in the first trimester.[2] A viable pregnancy is a pregnancy with the potential outcome of a live birth.[3] First-trimester vaginal bleeding and cramping are also common symptoms of early pregnancy loss and incomplete miscarriage. However, characteristic clinical findings of a threatened miscarriage are a closed cervical os, without passage of products of conception, and no evidence of fetal or embryonic demise on pelvic ultrasound.[4]

Approximately 25% of pregnancies have some degree of vaginal bleeding during the first trimester, and approximately half of these patients progress to early pregnancy loss.[4] The bleeding during a threatened miscarriage is typically mild to moderate; heavier bleeding that is more than typical menstrual flow is associated with an increased risk of pregnancy loss.[4] Intermittent cramping, suprapubic pain, pelvic pressure, or lower back pain are also common.[5][4]

Evaluation of threatened miscarriage depends on the pregnancy's gestational age. At early gestational ages, it is important to establish the location of the pregnancy to rule out an ectopic pregnancy, which can also present with vaginal bleeding and lower abdominal pain. Once an intrauterine pregnancy has been established, the clinician must determine the viability of the pregnancy, which is accomplished through a pelvic examination and ultrasound. If fetal cardiac activity is not seen, serial ultrasound examinations may be required to differentiate an early viable pregnancy from a pregnancy loss.[4]

Historically, the term "abortion" has been used to refer to any pregnancy loss before 20 weeks, though many leading professional organizations now recommend using variations of the terms "miscarriage" or "pregnancy loss" (eg, threatened miscarriage, threatened pregnancy loss) as patients prefer these terms.[2]


The exact etiology of a threatened miscarriage may not always be determined; however, possible causes include subchorionic hemorrhage or hematoma, eventual spontaneous miscarriage, or nonobstetric bleeding. Bleeding due to subchorionic hemorrhage or hematoma occurs in 18% to 22% of pregnancies, secondary to bleeding between the fetal membranes and the decidua basalis.[1] Though small subchorionic hematomas are not associated with an increased risk of miscarriage, hematomas that measure large than two-thirds of the gestational sac circumference have been found to have an increased risk of progressing to pregnancy loss.[6] In cases where bleeding is related to an impending early pregnancy loss, fetal chromosomal abnormalities, the most common underlying etiology of all early miscarriages, are present in at least half of affected pregnancies.[2][7][8] Nonobstetric causes of bleeding in viable intrauterine pregnancies include vaginitis, cervicitis, or cervical polyps.[4]


Threatened miscarriage can occur in any pregnancy regardless of maternal age, race, comorbidities, lifestyle, or socioeconomic status.[9] Approximately 25% of pregnant people have some amount of vaginal bleeding or spotting during the first trimester; in pregnancies with detectable fetal cardiac activity, 11% ultimately miscarry.[4]


The pathophysiology of threatened miscarriage depends on the underlying etiology of the symptoms. Subchorionic hemorrhage is caused by bleeding between the decidua basalis and the gestational sac.[1]  Conditions causing nonobstetric bleeding and cramping (eg, cervicitis or cervical trauma) include infectious processes leading to vascular permeability and cytokine-mediated inflammation of cervical and vaginal mucosa and trauma-related injury to the maternal abdomen or pelvic organs.[4][10][11]

History and Physical


Patients with a threatened miscarriage typically present with bleeding and cramping in the first trimester, though some patients may be unaware of their pregnancy and complain of irregular menstrual bleeding.[12]  These symptoms may occur during normal and abnormal gestations (eg, ectopic and molar pregnancies); therefore, a comprehensive evaluation must be conducted to exclude more concerning pregnancy complications.[2] A thorough medical history should be obtained, including an obstetrical and menstrual history. Clinicians can calculate an estimated due date using the first day of the last menstrual period; though, a first-trimester obstetrical ultrasound is considered more accurate and should be used to determine the gestational age if available.[4]  Previous ultrasounds can also help confirm that the pregnancy is located within the uterus.[4][12]

In a threatened miscarriage, the volume of bleeding can range from light spotting to bleeding heavier than a typical menstrual period; in general, the heavier the bleeding, the more concerning it is that the pregnancy will result in a miscarriage.[13][14] Patients with threatened miscarriages are almost always hemodynamically stable; even patients expectantly managed that proceed to have spontaneous pregnancy loss only require a blood transfusion 1% of the time.[15] The clinician should estimate the amount of bleeding a patient is experiencing by asking when the bleeding began, how often she is soaking or changing menstrual hygiene products, if she is passing any clots or tissue, and if she has any associated symptoms, such as dizziness or lightheadedness.[12] The provider should also ask about precipitating factors; if the bleeding started after cervical contact (eg, after intercourse or a pelvic exam), this might indicate cervical or vaginal, rather than uterine, pathology.[12]

Additionally, the provider should elicit the characteristics of any associated pain or cramping, the severity of which can vary widely.[12] On one end of the spectrum, bleeding may be completely painless, while for other patients, the bleeding may be accompanied by intensely painful menstrual-like cramping that radiates to the back and upper thighs. Like with bleeding, severe pain is more concerning for impending pregnancy loss.[14]

Physical Exam Findings

Key components of the physical examination should include an assessment of the patient's hemodynamic stability, including a review of the vital signs and a focused abdominal and pelvic examination.[12] Patients with only a threatened miscarriage will be hemodynamically stable and have normal cardiovascular and respiratory findings; hemodynamic instability indicates heavier bleeding that is more commonly seen with miscarriages in progress (eg, incomplete miscarriage).[2] The abdominal exam is also typically benign (eg, non-tender, non-distended, and soft), though patients may have mild tenderness to palpation in the lower pelvis over the uterus. Peritoneal signs, such as guarding, rebound tenderness, or abdominal rigidity, are not typically present in an uncomplicated threatened miscarriage; if found, they indicate the need for an emergent obstetrical or general surgery consultation.[4]

A pelvic exam is mandatory whenever a pregnant patient presents with bleeding to assess the amount and site of bleeding, cervical dilation, possible nonobstetric sources of bleeding, and whether fetal tissue is present in the cervix or vagina.[4] During the pelvic exam, suction, cotton swabs, or ring forceps may be needed to remove blood in the vagina or cervix to allow for better visualization; the clinician should assess any vaginal discharge and collect specimens as needed for testing.[4][16]  

In a threatened miscarriage, the typical findings during vaginal examination are a closed cervical os with no fetal or embryonic tissue in the vaginal vault, though blood may be noted.[1] There is usually no cervical motion tenderness, though depending on the severity of cramping, patients may note some uterine or adnexal discomfort.[16] Significant tenderness of the pelvic organs, especially if purulent vaginal discharge is present, suggests the presence of an infection.[16]

The pelvic exam is also essential to rule out alternative causes of vaginal bleeding in pregnancy, including vulvar, vaginal, and cervical lacerations, erosions, dysplasia or neoplasms, polyps, fibroids, or friability in the setting of an infection (eg, vaginal candidiasis, Chlamydia trachomatis infection, condyloma acuminata). Additionally, an adnexal mass may suggest an ectopic pregnancy or other gynecologic pathologies, such as a cyst or ovarian torsion.[14]


Components of the Evaluation

In addition to a history and physical exam, components of the diagnostic evaluation of a threatened miscarriage include:

  • Pelvic ultrasound
  • Serum quantitative beta-human chorionic gonadotropin (β-hCG) 
  • Blood type and Rh status
  • Hemoglobin and hematocrit
  • Additional labs for concerns of infection (eg, cultures of endocervical secretions, blood, and urine; complete blood count with a differential; comprehensive metabolic panel; and serum lactate)[4]

Pelvic Ultrasound

Transvaginal ultrasound is preferred over other modalities for the evaluation of first-trimester pregnancies.[6] In correlation with β-hCG levels, it is used to locate the pregnancy, determine the viability and gestational age of the pregnancy, and assess the pelvis for other contributing complications.[1] 

Assessing location: Threatened miscarriage is considered a diagnosis of exclusion; the most important diagnosis to rule out when evaluating bleeding in early pregnancy is an ectopic pregnancy, which commonly presents with bleeding and abdominal pain.[17] In a threatened miscarriage, an intrauterine pregnancy will be identified, or if neither an early intrauterine nor ectopic pregnancy is visualized, a pregnancy of unknown location (PUL) may be diagnosed. Embryonic or fetal structures (eg, a yolk sac or fetus) must be seen within the endometrial cavity to confirm an intrauterine pregnancy. A PUL is considered a temporary diagnosis that eventually must be determined to be an ectopic pregnancy, a miscarriage, or a very early intrauterine pregnancy through serial ultrasounds and β-hCG levels.[18]  

Assessing viability: The pregnancy is considered viable if fetal cardiac activity (FCA) is present. At earlier gestational ages before the development of FCA, intrauterine pregnancy failure may be identified based on a set of ultrasound criteria from a 2012 multispecialty panel from the Society of Radiologists in Ultrasound.[18][2][18] According to these criteria, pregnancy failure may be highly likely if one of the following is present: 

  • A fetal crown-rump length (CRL) of ≥7 mm without FCA
  • A mean sac diameter (MSD) of ≥25 mm without an embryo
  • Absence of an embryo with FCA ≥14 days after a scan showing a gestational sac (GS) without a yolk sac (YS)
  • Absence of an embryo with FCA ≥11 days after a scan showing a GS with a YS

Assessing the pelvis for nonobstetric causes of presentation: Ultrasound is the imaging modality of choice to evaluate the internal pelvic organs. In addition to looking for evidence of an ectopic pregnancy, ultrasound can assist in assessing other alternative diagnoses, including ruptured or torsed adnexal masses, gestational trophoblastic disease, and appendicitis.[14] Additional imaging, such as an abdominal radiograph or CT scan, can also be considered, depending on the severity of the presentation and clinical suspicion.[19]

Laboratory Evaluation

Quantitative β-hCG level: Early in gestation, the serum β-hCG increases at a relatively predictable rate in viable intrauterine pregnancies (IUPs); this increase may be abnormally slow in ectopic pregnancy or decrease in failing pregnancies. Therefore, serial β-hCG levels can help identify abnormal early pregnancies. For patients with a PUL, the trend in serial β-hCG levels, interpreted in conjunction with serial pelvic ultrasound examinations, is used to make the final diagnosis.[2][18] Once FCA is visible, however, normal β-hCG values can vary widely, with the rate of increase slowing over time, ultimately plateauing by about 10 weeks of gestation. For this reason, once FCA has been detected in an IUP, an β-hCG level is generally not indicated, and transvaginal ultrasound should primarily be used for diagnosis.[4]  In patients who already have evidence of an IUP but do not yet demonstrate a fetus with FCA (eg, a transvaginal ultrasound demonstrating only an intrauterine GS with a YS), an β-hCG level can be appropriate, as falling levels may identify a miscarriage sooner than if the clinician is relying on ultrasound alone; in these situations, however, a repeat β-hCG level is not strictly required since ectopic pregnancy has already been ruled out based on the ultrasound findings.[20][21][22]

Blood count: Assessment of the hemoglobin and hematocrit, typically with a complete blood count, is usually recommended except in cases where bleeding is scant (eg, an episode of spotting) and a baseline blood count was recently done (eg, at a recent initial prenatal visit). However, assessing the degree of blood loss is appropriate for most patients.[4][23]

Blood type and Rh status: In patients with significant vaginal bleeding, blood type and Rh status should be confirmed in anticipation of possible blood transfusion, surgical blood loss, or Rh(D)-alloimmunization prophylaxis.[4] If the pregnant person is Rh(D)-negative, they may develop antibodies against the Rh(D) antigen if they are exposed to Rh(D)-positive fetal blood. This is known as alloimmunization and can lead to future hemolytic disease of the newborn.[24] Knowledge of a patient's Rh status becomes more important as the pregnancy progresses due to the risk of Rh(D)-alloimmunization increasing as the number of fetal erythrocytes increases.[2] Approximately 11% of patients with a threatened miscarriage may experience maternal exposure to fetal blood and thus be at risk for alloimmunization.[25] Patients at risk of alloimmunization (eg, an Rh-negative pregnant person with bleeding) can be given Rh(D)-immune globulin to prevent the development of these antibodies; however, international guidelines vary regarding its use in the first trimester.[24]

Additional labs: A urinalysis is typically obtained as a urinary tract infection (UTI) may present with similar signs and symptoms. If there is a concern for a pelvic infection based on the patient's history and exam, additional testing is recommended, including blood and urine cultures,  sexually transmitted infection cultures, serum lactate, and a comprehensive metabolic panel.[19] 

Treatment / Management

Expectant Management

Patients with viable intrauterine pregnancies diagnosed with a threatened miscarriage should be expectantly managed after the exclusion of differential diagnoses. A pelvic ultrasound should be repeated if any further bleeding occurs. In patients in which the pregnancy's viability or location is uncertain, pelvic ultrasound should be repeated and serial β-hCG levels performed. For PULs in patients who remain hemodynamically stable, an β-hCG level should be obtained every 48 hours until the location of the pregnancy or pregnancy failure is identified.[2]

Progesterone supplementation has been investigated as a possible therapy to reduce the risk of pregnancy loss in patients at high risk for miscarriage, including those with a threatened miscarriage or a shortened cervix.[26][27] For people without a history of miscarriage, vaginal progesterone likely has little to no benefit. It is generally not recommended unless they are found to have a cervical length of 25 mm or less.[27][28][27][29] Evidence from the recent PRISM and PROMISE trials suggests that for people with a history of prior early pregnancy loss, vaginal progesterone does appear to be beneficial. Study authors recommended vaginal micronized progesterone 400 mg twice daily, initiated when a patient presents with symptoms of vaginal bleeding, continuing until 16 weeks of gestation.[26] 

Prevent Alloimmunization

Alloimmunization can be prevented by administering Rh(D)-immune globulin; however, guidelines vary, and its use in the first trimester is somewhat controversial due to the low risk of alloimmunization in the first trimester.[24] The Rh(D)-antigen is found on fetal erythrocytes, so alloimmunization is theoretically improbable before the development of these cells. The Rh(D)-antigen has been identified as early as 7 3/7 weeks of gestation.[24] Additionally, only 3% to 11% of pregnant people may be exposed to fetal blood during a threatened miscarriage, with the risk of alloimmunization increasing with heavier bleeding, older gestational age, and surgical procedures, such as chorionic villus sampling.

Given a lack of clear evidence to guide decision-making, the American College of Obstetricians and Gynecologists (ACOG) recommends that Rh(D)-immune globulin be considered for all Rh(D)-negative patients who have vaginal bleeding in early pregnancy, "especially those that are later in the first trimester."[24][30] Conversely, the National Institutes of Health and Care Excellence (NICE) guidelines from the UK explicitly recommend against its use before 12 weeks of gestation, while guidelines from the British Committee for Standards in Haematology (BCSH) that are supported by the Royal College of Obstetricians and Gynaecologists (RCOG) do consider it appropriate to give before 12 weeks when uterine bleeding is "repeated, heavy, or associated with abdominal pain."[31]

If given in the first trimester, a dose of Rh(D)-immune globulin 50-120 mcg IM once is effective at alloimmunization prevention; after 12 weeks of gestation, Rh(D)-immune globulin 300 mcg IM once is typically preferred in the US, though other guidelines recommend lower doses depending on the situation.[32] 

Discharge Instructions and Appropriate Follow-up

The importance of follow-up should be emphasized, and patients should be instructed to return for evaluation earlier than scheduled if they experience excessive vaginal bleeding, typically defined as soaking at least 1 to 2 pads for at least 2 hours in a row, worsening abdominal pain, or fever. Patients should also be reassured that they are not at fault for causing symptoms.[2]

There is no evidence that bed rest prevents early pregnancy loss and should not be recommended.[4][33][34]  Some clinicians prefer to advise patients to avoid strenuous activities and maintain pelvic rest (ie, avoiding vaginal intercourse) at least until the cessation of vaginal bleeding. However, this recommendation is not based on evidence. Clinicians should recommend that patients start or continue to take prenatal vitamins with folic acid supplementation.[35][36][37][38]

Differential Diagnosis

Clinicians should consider several differential diagnoses when a pregnant person presents with vaginal bleeding and pelvic pain, as threatened miscarriage is ultimately a diagnosis of exclusion.[14][39] The differential diagnosis includes:

  • Obstetric diagnoses
    • Ectopic pregnancy
    • Early pregnancy loss (eg, inevitable, incomplete, complete, or septic miscarriage)
    • Gestational trophoblastic disease
    • Cervical incompetence, typically in the second trimester
  • Vulvar, vaginal, and cervical diagnoses (eg, trauma, vaginal candidiasis, bacterial vaginosis, Chlamydia trachomatis infection, condyloma acuminata, cervical polyps, cervical malignancy)
  • Adnexal diagnoses (eg, ruptured corpus luteal cyst, adnexal torsion)
  • Other diagnoses (eg, appendicitis, urinary tract infection, inflammatory bowel disease) 

Ultrasound and β-hCG assessments can rule out ectopic pregnancy and early pregnancy loss. Differentiation of threatened miscarriage from other early pregnancy loss is primarily based on pelvic ultrasound and physical examination findings. In a threatened miscarriage, the cervical os is closed, and an ultrasound demonstrates evidence of a viable pregnancy.[40] These observations differentiate a threatened miscarriage from other types of miscarriage. For example, with an inevitable miscarriage, the cervical os is open without visualization of POC in the vaginal vault. In contrast, an open cervix with partial passage of POC characterizes an incomplete miscarriage. A nonviable pregnancy excludes the diagnosis of threatened miscarriage.[1] Ultrasound and history can also help rule out other adnexal and nonobstetric causes, such as appendicitis. Physical examinations and clinically appropriate testing can typically rule out vulvar, vaginal, and cervical causes.


Bleeding and cramping in early pregnancy are extremely common. Studies have shown that about 25% of pregnant people experience vaginal bleeding before 20 weeks of gestation, and between 12% to 57% of these patients will ultimately progress to early pregnancy loss. Heavy bleeding, especially when accompanied by pain or cramping, carries a significantly worse prognosis than light bleeding or spotting.[4][23]

Pregnancies complicated by threatened miscarriage also have an increased risk of adverse outcomes later in pregnancy, including pregnancy loss, preterm birth, preterm premature rupture of membranes, intrauterine fetal growth restriction, and placental abruption. Furthermore, patients who proceed to experience early pregnancy loss have an increased risk of depression, sleep disturbance, anger, and marital disturbances.[27]


Complications of threatened miscarriage include:

  • Early pregnancy loss 
  • Anemia
  • Poor mental health (eg, depression, anxiety)
  • Adverse outcomes later in pregnancy (eg, preterm labor, placental abruption) [27]


An obstetrical clinician should be consulted for patients with bleeding during pregnancy. For most stable patients who present to an emergency department, outpatient referral to an obstetrical specialist for close follow-up and prenatal care is appropriate. However, an obstetrician should be consulted immediately in patients with hemodynamic instability or in cases of diagnostic uncertainty.[4] 

Persistent bleeding in pregnancy may also warrant referral to a maternal-fetal medicine (MFM) specialist. Patients with recurrent pregnancy loss can be referred to a reproductive endocrinology and infertility (REI) specialist.[9] 

Deterrence and Patient Education

Patient education should be provided in both written and verbal forms. The patient should be informed if the pregnancy is viable and that continuation of the pregnancy commonly occurs, especially if the bleeding is light and there is no accompanying discomfort. She should be counseled on the risk of progression to miscarriage and that there may be no proven prevention strategies in many cases. Patients may feel extreme guilt or anxiety during a threatened miscarriage, and it is essential to reassure the patient that she is not at fault should a miscarriage occur.[4] 

Providers should explain what to expect during expectant management, including normal symptoms (eg, mild to moderate bleeding and cramping); for any uncontrolled pain, fever, or heavy bleeding defined as soaking 1 to 2 pads per hour for ≥2 hours, they should be evaluated promptly by an obstetric care provider or in the emergency department.[41][4]

Patients can be offered acetaminophen or paracetamol for pain relief but should generally be instructed to avoid NSAIDs while the pregnancy is still viable. Bedrest and activity restriction should not be recommended, though many providers recommend pelvic rest until symptoms resolve despite a lack of evidence supporting this recommendation.[4][2]

Pearls and Other Issues

  • A threatened miscarriage is a diagnosis of exclusion that should be made in pregnant patients determined to have viable pregnancies with symptoms of vaginal bleeding.
  • Subchorionic hematomas are associated with threatened miscarriage; pregnancies with large subchorionic hematomas have a higher risk of early pregnancy loss.
  • The initial steps when evaluating bleeding in early pregnancy are to determine the location of the pregnancy and then assess viability using ultrasound. 
  • Patients with heavy vaginal bleeding require evaluation for hemorrhagic anemia; it often indicates impending early pregnancy loss.
  • Patients with a threatened miscarriage can be managed as an outpatient with close follow-up and serial ultrasound monitoring as indicated.[1][4]

Enhancing Healthcare Team Outcomes

Diagnosing and managing a threatened miscarriage involves an interprofessional team, including emergency care clinicians, obstetric clinicians, radiology team members, midlevel practitioners, and nursing staff. Coordinating appropriate follow-up for these patients is critical and often involves cooperation between staff members in different departments or practices. Excellent documentation in the medical record, including all lab and radiology reports, is essential to ensure a patient receives optimal care at their follow-up appointment. Furthermore, nonclinical and clinical staff should be trained in communicating sensitively with patients experiencing early pregnancy complications.

Review Questions


Murugan VA, Murphy BO, Dupuis C, Goldstein A, Kim YH. Role of ultrasound in the evaluation of first-trimester pregnancies in the acute setting. Ultrasonography. 2020 Apr;39(2):178-189. [PMC free article: PMC7065984] [PubMed: 32036643]
American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No. 200: Early Pregnancy Loss. Obstet Gynecol. 2018 Nov;132(5):e197-e207. [PubMed: 30157093]
American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine. Ecker JL, Kaimal A, Mercer BM, Blackwell SC, deRegnier RA, Farrell RM, Grobman WA, Resnik JL, Sciscione AC. #3: Periviable birth. Am J Obstet Gynecol. 2015 Nov;213(5):604-14. [PubMed: 26506448]
Hendriks E, MacNaughton H, MacKenzie MC. First Trimester Bleeding: Evaluation and Management. Am Fam Physician. 2019 Feb 01;99(3):166-174. [PubMed: 30702252]
Karataşlı V, Kanmaz AG, İnan AH, Budak A, Beyan E. Maternal and neonatal outcomes of adolescent pregnancy. J Gynecol Obstet Hum Reprod. 2019 May;48(5):347-350. [PubMed: 30794955]
Expert Panel on Women’s Imaging: Brown DL, Packard A, Maturen KE, Deshmukh SP, Dudiak KM, Henrichsen TL, Meyer BJ, Poder L, Sadowski EA, Shipp TD, Simpson L, Weber TM, Zelop CM, Glanc P. ACR Appropriateness Criteria® First Trimester Vaginal Bleeding. J Am Coll Radiol. 2018 May;15(5S):S69-S77. [PubMed: 29724428]
Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012 Nov;98(5):1103-11. [PubMed: 22835448]
Yang J, Chen M, Ye X, Chen F, Li Y, Li N, Wu W, Sun J. A cross-sectional survey of pregnant women's knowledge of chromosomal aneuploidy and microdeletion and microduplication syndromes. Eur J Obstet Gynecol Reprod Biol. 2021 Jan;256:82-90. [PubMed: 33176246]
Devall AJ, Coomarasamy A. Sporadic pregnancy loss and recurrent miscarriage. Best Pract Res Clin Obstet Gynaecol. 2020 Nov;69:30-39. [PubMed: 32978069]
Tantengco OAG, Menon R. Breaking Down the Barrier: The Role of Cervical Infection and Inflammation in Preterm Birth. Front Glob Womens Health. 2021;2:777643. [PMC free article: PMC8803751] [PubMed: 35118439]
Jain V, Chari R, Maslovitz S, Farine D, Maternal Fetal Medicine Committee. Bujold E, Gagnon R, Basso M, Bos H, Brown R, Cooper S, Gouin K, McLeod NL, Menticoglou S, Mundle W, Pylypjuk C, Roggensack A, Sanderson F. Guidelines for the Management of a Pregnant Trauma Patient. J Obstet Gynaecol Can. 2015 Jun;37(6):553-74. [PubMed: 26334607]
Pontius E, Vieth JT. Complications in Early Pregnancy. Emerg Med Clin North Am. 2019 May;37(2):219-237. [PubMed: 30940368]
Chamberlain G. ABC of antenatal care, Vaginal bleeding in early pregnancy--I. BMJ. 1991 May 11;302(6785):1141-3. [PMC free article: PMC1669806] [PubMed: 2043788]
Knez J, Day A, Jurkovic D. Ultrasound imaging in the management of bleeding and pain in early pregnancy. Best Pract Res Clin Obstet Gynaecol. 2014 Jul;28(5):621-36. [PubMed: 24841987]
Nanda K, Lopez LM, Grimes DA, Peloggia A, Nanda G. Expectant care versus surgical treatment for miscarriage. Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD003518. [PMC free article: PMC6464924] [PubMed: 22419288]
Curry A, Williams T, Penny ML. Pelvic Inflammatory Disease: Diagnosis, Management, and Prevention. Am Fam Physician. 2019 Sep 15;100(6):357-364. [PubMed: 31524362]
American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No. 193: Tubal Ectopic Pregnancy. Obstet Gynecol. 2018 Mar;131(3):e91-e103. [PubMed: 29470343]
Doubilet PM, Benson CB, Bourne T, Blaivas M, Society of Radiologists in Ultrasound Multispecialty Panel on Early First Trimester Diagnosis of Miscarriage and Exclusion of a Viable Intrauterine Pregnancy. Barnhart KT, Benacerraf BR, Brown DL, Filly RA, Fox JC, Goldstein SR, Kendall JL, Lyons EA, Porter MB, Pretorius DH, Timor-Tritsch IE. Diagnostic criteria for nonviable pregnancy early in the first trimester. N Engl J Med. 2013 Oct 10;369(15):1443-51. [PubMed: 24106937]
Eschenbach DA. Treating spontaneous and induced septic abortions. Obstet Gynecol. 2015 May;125(5):1042-1048. [PubMed: 25932831]
Alves C, Jenkins SM, Rapp A. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Oct 12, 2023. Early Pregnancy Loss (Spontaneous Abortion) [PubMed: 32809356]
Dugas C, Slane VH. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jun 27, 2022. Miscarriage. [PubMed: 30422585]
Mummert T, Gnugnoli DM. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Aug 8, 2023. Ectopic Pregnancy. [PubMed: 30969682]
Prine LW, MacNaughton H. Office management of early pregnancy loss. Am Fam Physician. 2011 Jul 01;84(1):75-82. [PubMed: 21766758]
Practice Bulletin No. 181: Prevention of Rh D Alloimmunization. Obstet Gynecol. 2017 Aug;130(2):e57-e70. [PubMed: 28742673]
Von Stein GA, Munsick RA, Stiver K, Ryder K. Fetomaternal hemorrhage in threatened abortion. Obstet Gynecol. 1992 Mar;79(3):383-6. [PubMed: 1738519]
Coomarasamy A, Devall AJ, Brosens JJ, Quenby S, Stephenson MD, Sierra S, Christiansen OB, Small R, Brewin J, Roberts TE, Dhillon-Smith R, Harb H, Noordali H, Papadopoulou A, Eapen A, Prior M, Di Renzo GC, Hinshaw K, Mol BW, Lumsden MA, Khalaf Y, Shennan A, Goddijn M, van Wely M, Al-Memar M, Bennett P, Bourne T, Rai R, Regan L, Gallos ID. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence. Am J Obstet Gynecol. 2020 Aug;223(2):167-176. [PMC free article: PMC7408486] [PubMed: 32008730]
Wahabi HA, Fayed AA, Esmaeil SA, Bahkali KH. Progestogen for treating threatened miscarriage. Cochrane Database Syst Rev. 2018 Aug 06;8(8):CD005943. [PMC free article: PMC6513446] [PubMed: 30081430]
Prediction and Prevention of Spontaneous Preterm Birth: ACOG Practice Bulletin, Number 234. Obstet Gynecol. 2021 Aug 01;138(2):e65-e90. [PubMed: 34293771]
Ali S, Majid S, Niamat Ali M, Taing S, El-Serehy HA, Al-Misned FA. Evaluation of etiology and pregnancy outcome in recurrent miscarriage patients. Saudi J Biol Sci. 2020 Oct;27(10):2809-2817. [PMC free article: PMC7499272] [PubMed: 32994741]
Mayekar RV, Paradkar GV, Bhosale AA, Sachan R, Beeram S, Anand AR, Mundle SR, Trivedi Y, Md R, Patole KP, Sambarey PW, Daftary GV, John J, Divekar GH. Recombinant anti-D for prevention of maternal-foetal Rh(D) alloimmunization: a randomized multi-centre clinical trial. Obstet Gynecol Sci. 2020 May;63(3):315-322. [PMC free article: PMC7231934] [PubMed: 32489976]
Qureshi H, Massey E, Kirwan D, Davies T, Robson S, White J, Jones J, Allard S., British Society for Haematology. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus Med. 2014 Feb;24(1):8-20. [PubMed: 25121158]
Yoham AL, Casadesus D. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): May 22, 2023. Rho(D) Immune Globulin. [PubMed: 32491807]
Aleman A, Althabe F, Belizán J, Bergel E. Bed rest during pregnancy for preventing miscarriage. Cochrane Database Syst Rev. 2005 Apr 18;2005(2):CD003576. [PMC free article: PMC8721648] [PubMed: 15846669]
Walsh CA. Maternal activity restriction to reduce preterm birth: Time to put this fallacy to bed. Aust N Z J Obstet Gynaecol. 2020 Oct;60(5):813-815. [PubMed: 32691407]
Morin L, Cargill YM, Glanc P. Ultrasound Evaluation of First Trimester Complications of Pregnancy. J Obstet Gynaecol Can. 2016 Oct;38(10):982-988. [PubMed: 27720100]
Huchon C, Deffieux X, Beucher G, Capmas P, Carcopino X, Costedoat-Chalumeau N, Delabaere A, Gallot V, Iraola E, Lavoue V, Legendre G, Lejeune-Saada V, Leveque J, Nedellec S, Nizard J, Quibel T, Subtil D, Vialard F, Lemery D., Collège National des Gynécologues Obstétriciens Français. Pregnancy loss: French clinical practice guidelines. Eur J Obstet Gynecol Reprod Biol. 2016 Jun;201:18-26. [PubMed: 27039249]
Mellerup N, Sørensen BL, Kuriigamba GK, Rudnicki M. Management of abortion complications at a rural hospital in Uganda: a quality assessment by a partially completed criterion-based audit. BMC Womens Health. 2015 Sep 20;15:76. [PMC free article: PMC4576397] [PubMed: 26388296]
Schindler AE, Carp H, Druckmann R, Genazzani AR, Huber J, Pasqualini J, Schweppe KW, Szekeres-Bartho J. European Progestin Club Guidelines for prevention and treatment of threatened or recurrent (habitual) miscarriage with progestogens. Gynecol Endocrinol. 2015 Jun;31(6):447-9. [PubMed: 25976550]
Milman T, Walker M, Thomas J. Pregnancy of unknown location. CMAJ. 2020 Sep 28;192(39):E1132. [PMC free article: PMC7532014] [PubMed: 32989026]
Redinger A, Nguyen H. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jun 27, 2022. Incomplete Abortions. [PubMed: 32644497]
Webster K, Eadon H, Fishburn S, Kumar G., Guideline Committee. Ectopic pregnancy and miscarriage: diagnosis and initial management: summary of updated NICE guidance. BMJ. 2019 Nov 13;367:l6283. [PubMed: 31722871]

Disclosure: MIchelle Mouri declares no relevant financial relationships with ineligible companies.

Disclosure: Heather Hall declares no relevant financial relationships with ineligible companies.

Disclosure: Timothy Rupp declares no relevant financial relationships with ineligible companies.

Copyright © 2024, StatPearls Publishing LLC.

This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.

Bookshelf ID: NBK430747PMID: 28613498


  • PubReader
  • Print View
  • Cite this Page

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...